
Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings
Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于持股5%以上股东拟转让部分质押股份的提示性公告 | 2023-05-11 | Chinese | |
| 关于持股5%以上股东部分股份解除质押的公告 | 2023-05-08 | Chinese | |
| 关于举行2022年度网上业绩说明会的公告 | 2023-05-05 | Chinese | |
| 关于持股5%以上股东部分股份解除质押的公告 | 2023-05-04 | Chinese | |
| 关于公司副总经理、董事会秘书辞职暨聘任董事会秘书的公告 | 2023-04-28 | Chinese | |
| 第四届董事会第二十三次会议决议公告 | 2023-04-28 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 39721452 | 关于持股5%以上股东拟转让部分质押股份的提示性公告 | 2023-05-11 | Chinese | ||
| 39721440 | 关于持股5%以上股东部分股份解除质押的公告 | 2023-05-08 | Chinese | ||
| 39721430 | 关于举行2022年度网上业绩说明会的公告 | 2023-05-05 | Chinese | ||
| 39721424 | 关于持股5%以上股东部分股份解除质押的公告 | 2023-05-04 | Chinese | ||
| 39721415 | 关于公司副总经理、董事会秘书辞职暨聘任董事会秘书的公告 | 2023-04-28 | Chinese | ||
| 39721406 | 第四届董事会第二十三次会议决议公告 | 2023-04-28 | Chinese | ||
| 39721395 | 关于聘任证券事务代表的公告 | 2023-04-28 | Chinese | ||
| 39721384 | 独立董事关于第四届董事会第二十三次会议相关事项的独立意见 | 2023-04-28 | Chinese | ||
| 39721373 | 关于持股5%以上股东减持公司股份累计超过1%的公告 | 2023-04-27 | Chinese | ||
| 39721364 | 关于持股5%以上股东部分股份解除质押的公告 | 2023-04-27 | Chinese | ||
| 39721354 | 第四届监事会第十六次会议决议公告 | 2023-04-25 | Chinese | ||
| 39721347 | 中天国富证券有限公司关于新乡拓新药业股份有限公司2022年度内部控制自我评价报告的核查意见 | 2023-04-25 | Chinese | ||
| 39721335 | 关于聘任公司副总经理的公告 | 2023-04-25 | Chinese | ||
| 39721330 | 2022年年度审计报告 | 2023-04-25 | Chinese | ||
| 39721291 | 独立董事2022年度述职报告(刘建伟) | 2023-04-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Tuoxin Pharmaceutical Group Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56042/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56042 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56042 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56042 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56042}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tuoxin Pharmaceutical Group Co.,Ltd. (id: 56042)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.